Home › Funds › Sumitomo Mitsui Trust Group, Inc. › ABBV

Sumitomo Mitsui Trust Group, Inc. position in ABBV

ABBVIE INC · Health Care

Sumitomo Mitsui Trust Group, Inc. reported holding 3,828,108 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$1.00B, representing 0.57% of its reported portfolio and ranking #27 among its reported holdings. Sumitomo Mitsui Trust Group, Inc. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.83M sh
Reported value held$1.00B
Portfolio Weight0.57%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Sumitomo Mitsui Trust Group, Inc.'s ABBV position evolved

Sumitomo Mitsui Trust Group, Inc. first disclosed a stake in ABBV in Q3 2023 at 4,443,892 shares (US$662.4M). The position peaked in Q3 2026 at 3,828,108 shares, worth US$1.00B. Across 13 filings, Sumitomo Mitsui Trust Group, Inc. increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 3,828,108 shares valued at US$1.00B — a reduction of -117,438 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.44M $662.41M New
Q4 2023 4.43M $686.28M Hold
Q1 2024 4.37M $795.30M Reduce
Q2 2024 4.08M $699.87M Reduce
Q3 2024 4.12M $813.47M Add
Q4 2024 4.11M $730.98M Hold
Q1 2025 4.10M $859.79M Hold
Q2 2025 4.19M $777.69M Add
Q3 2025 4.26M $985.45M Add
Q4 2025 4.10M $937.46M Reduce
Q1 2026 3.91M $851.39M Reduce
Q2 2026 3.95M $992.86M Add
Q3 2026 3.83M $1.00B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Sumitomo Mitsui Trust Group, Inc. held ABBV?

Sumitomo Mitsui Trust Group, Inc. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Sumitomo Mitsui Trust Group, Inc.'s current position in ABBV?

As of Q3 2026, Sumitomo Mitsui Trust Group, Inc. holds 3.83M shares of ABBV (ABBVIE INC), valued at $1.00B, representing 0.57% of its reported portfolio and ranking #27.

Has Sumitomo Mitsui Trust Group, Inc. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Sumitomo Mitsui Trust Group, Inc. reduced its position in ABBV. The position peaked in Q3 2026 at 3.83M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.